Lithium sulphate - Karo Pharma

Drug Profile

Lithium sulphate - Karo Pharma

Alternative Names: Lithionit

Latest Information Update: 21 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator BioPhausia
  • Developer Karo Pharma AB
  • Class Alkali metals; Antidepressants; Antimanics; Antipsychotics; Light metals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Manic episodes

Most Recent Events

  • 21 Dec 2016 Chemical structure information added
  • 26 Jan 2001 Swedish Medical Products Agency approves lithium sulphate for Manic episodes (In patients with Bipolar disorders) in Sweden (PO, 83mg)
  • 14 Nov 1997 Launched for Manic episodes in Norway (PO) after November 1997
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top